The CHRM3 gene is implicated in abnormal thalamo-orbital frontal cortex functional connectivity in first-episode treatment-naive patients with schizophrenia.
BACKGROUND: The genetic influences in human brain structure and function and impaired functional connectivities are the hallmarks of the schizophrenic brain. To explore how common genetic variants affect the connectivities in schizophrenia, we applied genome-wide association studies assaying the abnormal neural connectivities in schizophrenia as quantitative traits. METHOD: We recruited 161 first-onset and treatment-naive patients with schizophrenia and 150 healthy controls. All the participants underwent scanning with a 3 T-magnetic resonance imaging scanner to acquire structural and functional imaging data and genotyping using the HumanOmniZhongHua-8 BeadChip. The brain-wide association study approach was employed to account for the inherent modular nature of brain connectivities. RESULTS: We found differences in four abnormal functional connectivities [left rectus to left thalamus (REC.L-THA.L), left rectus to right thalamus (REC.L-THA.R), left superior orbital cortex to left thalamus (ORBsup.L-THA.L) and left superior orbital cortex to right thalamus (ORBsup.L-THA.R)] between the two groups. Univariate single nucleotide polymorphism (SNP)-based association revealed that the SNP rs6800381, located nearest to the CHRM3 (cholinergic receptor, muscarinic 3) gene, reached genomic significance (p = 1.768 × 10-8) using REC.L-THA.R as the phenotype. Multivariate gene-based association revealed that the FAM12A (family with sequence similarity 12, member A) gene nearly reached genomic significance (nominal p = 2.22 × 10-6, corrected p = 0.05). CONCLUSIONS: Overall, we identified the first evidence that the CHRM3 gene plays a role in abnormal thalamo-orbital frontal cortex functional connectivity in first-episode treatment-naive patients with schizophrenia. Identification of these genetic variants using neuroimaging genetics provides insights into the causes of variability in human brain development, and may help us determine the mechanisms of dysfunction in schizophrenia.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| A regulatory variant of CHRM3 is associated with cannabis-induced hallucinations in European Americans. | 2019 | 31740666 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Polymorphisms in GPCR genes: Their role in schizophrenia, autism diseases and response to antipsychotic treatment - A systematic review. | DelaCuesta-Barrutia J et al. | — | 2026 | → |
| Acute Hypobaric Hypoxia Causes Alterations in Acetylcholine-Mediated Signaling Through Varying Expression of Muscarinic Receptors in the Prefrontal Cortex and Cerebellum of Rats' Brain. | Sharma NK et al. | — | 2025 | → |
| Comprehensive analysis of circRNA expression profile and circRNA-miRNA-mRNA network susceptibility to very early-onset schizophrenia. | Huang H et al. | — | 2023 | → |
| G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders. | Wong TS et al. | — | 2023 | → |
| A Novel 16-Genes Signature Scoring System as Prognostic Model to Evaluate Survival Risk in Patients with Glioblastoma. | Yu Z et al. | — | 2022 | → |
| Dynamic network impairments underlie cognitive fluctuations in Lewy body dementia. | Matar E et al. | — | 2022 | → |
| Integrative omics of schizophrenia: from genetic determinants to clinical classification and risk prediction. | Guan F et al. | — | 2022 | → |
| Shaping the Trans-Scale Properties of Schizophrenia <i>via</i> Cerebral Alterations on Magnetic Resonance Imaging and Single-Nucleotide Polymorphisms of Coding and Non-Coding Regions. | Zhao SW et al. | — | 2021 | → |
| Schizophrenia patients and their healthy siblings share decreased prefronto-thalamic connectivity but not increased sensorimotor-thalamic connectivity. | Xi C et al. | — | 2020 | → |
| A regulatory variant of CHRM3 is associated with cannabis-induced hallucinations in European Americans. | Cheng Z et al. | — | 2019 | → |
| Constitutional 763.3 Kb chromosome 1q43 duplication encompassing only CHRM3 gene identified by next generation sequencing (NGS) in a child with intellectual disability. | Cheng X et al. | — | 2019 | → |
| Genome-wide association analysis reveals KCTD12 and miR-383-binding genes in the background of rumination. | Eszlari N et al. | — | 2019 | → |
| GWAS and systems biology analysis of depressive symptoms among smokers from the COPDGene cohort. | Heinzman JT et al. | — | 2019 | → |
| Integration of methylation QTL and enhancer-target gene maps with schizophrenia GWAS summary results identifies novel genes. | Wu C et al. | — | 2019 | → |
| Salivary Flow Alteration in Patients Undergoing Treatment for Schizophrenia: Disease-Drug-Target Gene/Protein Association Study for Side-effects. | Mohandoss AA et al. | — | 2019 | → |
| Differences Between Schizophrenic and Normal Subjects Using Network Properties from fMRI. | Bae Y et al. | — | 2018 | → |
| The common variants implicated in microstructural abnormality of first episode and drug-naïve patients with schizophrenia. | Ren HY et al. | — | 2017 | → |